Complicated urinary tract infections

Current Infectious Disease Reports

Volumn 10, Issue 6, 2008, Pages 499-504

  Lichtenberger, Paola ^b   Hooton, Thomas M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; LEVOFLOXACIN; NITROFURAL;

ACUTE PYELONEPHRITIS; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIURIA; BLADDER CATHETERIZATION; CATHETER INFECTION; CLINICAL TRIAL; COCHRANE LIBRARY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; MATERIAL COATING; MEDICARE; NONHUMAN; PATHOGENESIS; RECURRENT INFECTION; REIMBURSEMENT; REVIEW; URINARY TRACT INFECTION;

EID: 63249094998     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-008-0081-0     Document Type: Review

References (25)

1. Hooton TM, Stamm WE: Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997, 11:551-581.
2. Hang L, Frendeus B, Godaly G, Svanborg C: Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis 2000, 182:1738-1748.
3. Frendeus B, Godalay G, Hang L, et al.: Interleukin-8 receptor deficiency confers susceptibility to acute pyelonephritis and may have a human counterpart. J Exp Med 2000, 192:881-890.
4. Hopkins WJ, Uehling DT, Wargowski DS: Evaluation of a familial predisposition to recurrent urinary tract infections in women. Am J Med Genet 1999, 83:422-424.
5. Lundstedt AC, McCarthy S, Gustafsson CU, et al.: A genetic basis of susceptibility to acute pyelonephritis. PloS ONE 2007, 2:e825.
6. Lundstendt AC, Leijonhufvud I, Ragnarsdottir B, et al.: Inherited susceptibility to acute pyelonephritis: A family study of urinary tract infection. J Infect Dis 2007, 195:1227-1234.
7. Saint S, Kaufman SR, Rogers MA, et al.: Condom versus indwelling urinary catheters: A randomized trial. J Am Geriatr Soc 2006, 54:1055-1061.
8. Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME: Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microb Rev 2008, 21:26-59.
9. Laehdevirta J, Tallgren KG, Kuhlbaeck B: System of closed, sterile urinary drainage with indwelling catheter. Duodecim 1963, 79:978-984.
10. Cornia PB, Amory JK, Fraser S, et al.: Computer based order entry decreases duration of indwelling urinary tract infections in hospitalized patients. Am J Med 2003, 114:404-407.
11. Apisarnthanarak A, Thongphubeth K, Sirinvaravong S, et al.: Effectiveness of multifaceted hospital wide quality improvement programs featuring an intervention to remove unnecessary urinary catheters at the tertiary care center in Thailand. Infect Control Hosp Epidemiol 2007, 28:791-798.
12. Polliack T, Bluvshtein V, Philo O, et al.: Clinical and economical consequences of volume-or time-dependent intermittent catheterization in patients with spinal cord lesions and neuropathic bladder. Spinal Cord 2005, 43:615-619.
13. Johnson JR. KAskowski MA, Wilt TJ: Systematic review: antimicrobial urinary catheters to prevent catheter associated urinary tract infection in hospitalized patients. Ann Intern Med 2006, 144:116-126.
14. Stensballe J, Tvede M, Looms D, et al.: Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients. Ann Intern Med 2007, 147:285-293.
15. Trautner BW, Hull RA, Thornby JI, Darouiche RO: Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect Control Hosp Epidemiol 2007, 28:92-94.
16. Niel-Weise BS, Van der Broek PJ: Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev 2005, 25(1):CD004201.
17. Salomon J, Denys P, Merle C, et al.: Prevention of urinary tract infection in spinal cord-injured patients: Safety and efficacy of a weekly oral cyclic antibiotic (WOCA) program with a 2 year follow-up-an observational prospective study. J Antimicrob Chemother 2006: 57:784-788.
18. Stickler DJ, Jones SM, Adusei GO, et al.: A clinical assessment of the performance of a sensor to detect crystalline biofilm formation on indwelling bladder catheters. BJU Int 2006, 98:1244-1249.
19. Hazan Z, Zumeris J, Jacob H, et al.: Effective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic waves. Antimicrob Agents Chemother 2006, 50:4144-4152.
20. Burton E, Gawande PV, Yakandawala K, et al.: Antibiofilm activity of GlmU enzyme inhibitors against catheter-associated uropathogens. Antimicrob Agents Chemother 2006, 50:1835-1840.
21. Peterson J, Kaul S, Khashab M, et al.: A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 2008, 71:17-22.
22. Dow G, Rao P, Harding G, et al.: A prospective, randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin Infect Dis 2004, 39:658-664.
23. Pohl A: Modes of administration of antibiotics for symptomatic severe urinary tract infections. Cochrane Database Syst Rev 2007, 4:CD003237.
24. Wald H, Kramer A: Nonpayment for harms resulting from medical care. Catheter-associated urinary tract infections. JAMA 2007, 298:2782-2784.
25. Saint S, Kowalski C, Kaufman S, et al.: Preventing hospital-acquired urinary tract infections in the United States: A national study. Clin Infect Dis 2008, 46:243-250.